×
About 1,310 results

ALLMedicine™ Atrophic Gastritis Center

Research & Reviews  474 results

Demographic, hematologic, and endoscopic differences between predominant corporeal and ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663852
Medicine Chibulcutean O, Gabor MR et. al.

Dec 11th, 2021 - The study aimed to assess demographic, clinical, and endoscopic parameters in patients with predominant corporeal atrophic gastritis (CAG) and enterochromaffin-like cell hyperplasia suggestive for autoimmune etiology in comparison with patients pr...

The circular RNA hsa_circ_000780 as a potential molecular diagnostic target for gastric...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627072
BMC Medical Genomics; Song J, Yu S et. al.

Nov 29th, 2021 - The present study aimed to identify a specific circular RNA (circRNA) for early diagnosis of gastric cancer (GC). Totally 82 patients with GC, 30 with chronic nonatrophic gastritis and 30 with chronic atrophic gastritis were included in this study...

Zuojin Pill attenuates Helicobacter pylori-induced chronic atrophic gastritis in rats a...
https://doi.org/10.1016/j.jep.2021.114855
Journal of Ethnopharmacology; Wen J, Wu S et. al.

Nov 23rd, 2021 - Zuojin pill (ZJP), a classical Chinese medicine formula, has been widely applied in Chinese clinical practice for the treatment of gastric injury such as acute gastric lesion, acute gastric mucosal injury, chronic unpredictable mild stress, gastro...

Lack of uniformity in reporting autoimmune gastritis among a diverse group of pathologi...
https://doi.org/10.1016/j.anndiagpath.2021.151840
Annals of Diagnostic Pathology; Bloomquist MS, Powell J et. al.

Nov 14th, 2021 - Autoimmune gastritis (AIG) is a clinicopathologic diagnosis requiring characteristic histopathology and correlation with laboratory work-up. To better understand how the diagnosis of AIG is made and reported in the pathology community, we conducte...

see more →

Guidelines  2 results

AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Exp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740554
Gastroenterology Shah SC, Piazuelo MB et. al.

Aug 30th, 2021 - The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis du...

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367502
Endoscopy Dinis-Ribeiro M, Areia M et. al.

Dec 27th, 2011 - Atrophic gastritis, intestinal metaplasia, and epithelial dysplasia of the stomach are common and are associated with an increased risk for gastric cancer. In the absence of guidelines, there is wide disparity in the management of patients with th...

see more →

Drugs  8 results see all →

Clinicaltrials.gov  17 results

European Registry on the Management of Helicobacter Pylori Infection
https://clinicaltrials.gov/ct2/show/NCT02328131

Aug 31st, 2021 - Abstract Introduction: H. pylori selectively infects the human stomach mucosa, being the most prevalent chronic infection in the world. Its prevalence correlates with socioeconomic factors and it is higher in older individuals. H. pylori presence ...

Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
https://clinicaltrials.gov/ct2/show/NCT03873584

Aug 19th, 2021 - The diagnosis of anemia is based on the patient's symptoms and blood tests. Blood tests refer to hemoglobin, hematocrit, and the number of red blood cells (per cubic centimeter or millet of blood). Also, the status of iron stores in the body can b...

Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis
https://clinicaltrials.gov/ct2/show/NCT04840056

Apr 9th, 2021 - This is a two-part retrospective study including a clinical data part and a pathology part. A training cohort will be developed from approximately 70% of included cases. It will be followed by a validation cohort with the remaining cases. Clinical...

Use of Blood Biomarkers to Predict Gastric Cancer Risk
https://clinicaltrials.gov/ct2/show/NCT04329299

Oct 22nd, 2020 - Objectives: This study aims to Validate the predictive value of various blood biomarkers, including the panel of antibodies against H.pylori and pepsinogen levels, micro RNAs (miRNAs) and blood-based protein markers in a prospective cohort study i...

Tongjiang Series Prescription Combined With PPIs Descending Ladder Withdrawal in Treating Nonerosive Reflux Disease
https://clinicaltrials.gov/ct2/show/NCT04340297

Jul 29th, 2020 - Nonerosive Reflux Disease (NERD) accounts for about 70% of Gastroesophageal Reflux Disease (GERD), which is a common refractory gastrointestinal disease. Proton Pump Inhibitors (PPIs), the preferred treatment, have the following problems in clinic...

see more →

News  23 results

Diagnosing and Managing Atrophic Gastritis: Expert Review
https://www.medscape.com/viewarticle/961530

Oct 25th, 2021 - A new clinical practice update expert review for the diagnosis and management of atrophic gastritis (AG) from the American Gastroenterological Association focuses on cases linked to Helicobacter pylori infection or autoimmunity. Dr Shailja C. Shah...

H. Pylori Tx Cuts Gastric Cancer Risk Long Term
https://www.medpagetoday.com/gastroenterology/pepticulcerdisease/89849

Nov 23rd, 2020 - Helicobacter pylori (H. pylori) therapy and eradication protected against progression to gastric cancer in Hispanic patients with pre-cancerous lesions, and the protective effect of therapy endured at 20 years, researchers reported. In the longest...

October 2019 - Quick Quiz Question 2
https://www.mdedge.com/gihepnews/article/208975/mixed-topics/october-2019-quick-quiz-question-2?channel=29259

Sep 27th, 2019 - Q2. Correct answer: C Rationale Vitamin B12 absorption requires intrinsic factor to bind B12 to facilitate absorption in the terminal ileum.

Diagnosis and management of gastric intestinal metaplasia in the United States
https://www.mdedge.com/gihepnews/article/205505/gi-oncology/diagnosis-and-management-gastric-intestinal-metaplasia-united
Diana Curras-Martin, MD, Susana Gonzalez, MD

Aug 1st, 2019 - Introduction Despite a global decline in the incidence of gastric cancer over the past 3 decades, it remains the fifth most commonly diagnosed cancer and the third most common cause of cancer deaths worldwide. 1 In the United States it is the fourt.

see more →